H. Fischer et al. / Journal of Organometallic Chemistry 620 (2001) 165–173
171
36.62 [NCH3], 58.9 [CMe2], 84.38 [C(H)Ph], 126.56,
3.6. Pentacarbonyl[4,5-dihydro-2-methylthiazole-
N]tungsten (11)
128.72, 129.05, 133.49 [Ph], 217.93 [cis-CO], 222.61
[trans-CO], 295.42 [C(carbene)]. MS m/z (%): 365 (12)
[M+], 309 (7) [M+−2CO], 281 (8) [M+−3CO], 253
(21) [M+−4CO], 225 (100) [M+−5CO].
At −30°C 0.36 ml (0.23 mmol) of 2-methyl 4,5-dihy-
drothiazole (8a) is added to the highly concentrated
solution of the alkyne complex [(CO)5W(H–CꢁC–Ph)].
The solution is stirred and gradually warmed to r.t. The
reaction is followed by IR spectroscopy. When the
w(CO) absorptions due to the alkyne complexes had
disappeared the solvent is removed in vacuo and the
reaction products are chromatographed at −30°C on
silica gel. First, [Cr(CO)6] and imine are eluted with
pentane. Next, with pentane–CH2Cl2 (10/3) a yellow
band containing the 2,4-dihydrothiazole complex is
eluted. Removal of the solvent in vacuo and recrystal-
lization from pentane–CH2Cl2 give yellow 11. Alterna-
tively, complex 11 is also obtained from the reaction of
[(CO)5W(THF)] with 8a. Yield 0.59 g (30% relative to
[Cr(CO)6]), M.p. 116°C. IR (pentane): w(CO) (cm−l):
3.5. Pentacarbonyl[1-(4,5-dihydro-2-methylthiazolium)-
2-methyl-1-propenyl]chromate (9a) and pentacarbonyl-
[4,5-dihydro-2-methylthiazole-N]chromium (10a)
When a green solution of [(CO)5CrꢀCꢀCMe2] (see
Section 3.2) is charged at −45°C with 0.36 ml (0.23
mmol) of 2-methyl 4,5-dihydrothiazole (8a) the color
immediately turns yellow. After stirring the solution for
15 min, it is allowed to warm to r.t. Stirring is contin-
ued for 1 h, the volume of the solution reduced in
vacuo to 5 and 50 ml of pentane is added. A yellow
precipitate forms. The suspension is kept at −20°C for
24 h and then fritted at r.t. through a 2-cm layer of
neutral alumina. The Al2O3 layer is eluted with 50 ml of
pentane. The volume of the combined pentane fractions
is reduced to ca. 7 ml. The solution is then chro-
matographed at −20°C on flash silica with pentane–
CH2Cl2 mixtures (ratio decreasing from 1:0 to 5:2). The
first yellow band contains [Cr(CO)6], the second one
complex 9a. Removal of the solvent of the second
fraction affords 80 mg (7.5% relative to [Cr(CO)6]) of
10a. The residue on top of the Al2O3 layer is dissolved
in 80 ml of CH2Cl2. The solvent is removed in vacuo
and the residue dissolved in 8 ml of diethyl ether. The
solution is kept at −20°C for 24 h and then filtered at
−18°C over a 6-cm layer of sand/glass wool/sand. The
layer is eluted with 8 ml of precooled diethyl ether. The
solvent is removed in vacuo to yield 0.56 g (11%
relative to [Cr(CO)6]) of 9a as a yellow solid. M.p.
108°C. IR (CH2C12): w(CO) (cm−l): 2042 m, 1958 w,
1
2070 w, 1932 vs, 1921 m. H-NMR (CDCl3): l 2.45 (s,
3
3H, CH3), 3.44 (t, J=8.6 Hz, 2H, SCH2), 4.42 (dt,
J=8.6 and 1.4 Hz, 2H, NCH2). 13C-NMR
(CD3COCD3): l 23.97 [CH3], 32.97, 76.01, 181.67
[NꢀC], 198.89 [JWC=130.5 Hz, cis-CO], 202.67 [trans-
CO]. MS: m/z (%). Anal. Found: C, 25.75; H, 1.80; N,
2.78. C9H7NO5SW (425.1) Calc.: C, 25.43; H, 1.66; N,
3.30%.
3.7. Pentacarbonyl[1-(4,5-dihydro-2-methyloxazolium)-
2-methyl-1-propenyl]chromate (9b) and pentacarbonyl-
[4,5-dihydro-2-methyloxazole-N]chromium (10b)
The synthesis from 2.80 g (12.8 mmol) of [Cr(CO)6],
4.76 g (25.5 mmol) of C9K2, 1.3 ml of isobutyryl
chloride (12.8 mmol), and 0.54 ml (6.38 mmol) of
2-methyl 4,5-dihydrooxazole (8b) and the purification
of the products are carried out analogously to 3.2 and
3.6.
1
1911 vs, 1904 vs. H-NMR (CD3COCD3): l 1.54 and
1.92 (2 s, 3 H each, CꢀCCH3), 2.43 (s, 3H, NꢀCCH3),
3.81 (t, 3J=8.8 Hz, 2H, SCH2), 4.35 (dt, 2J=12.8,
2
3
3J=8.8 Hz, 1H, NCH2), 4.94 (dt, J=12.8, J=8.8
Hz, 1H, NCH2). 13C-NMR (CD3COCD3, for the num-
bering scheme see Fig. 2): l 17.62, 20.17 [C(8), C(9)],
25.87 [C(13)], 28.73 [C(11)], 61.85 [C(12)], 139.14,
161.23 [C(6), C(7)], 173.85 [C(10)], 221.35 [cis-CO],
224.44 [trans-CO]. MS m/z (%): 347 (4) [M+], 319 (1)
[M+−2CO], 291 (1) [M+−2CO], 263 (1) [M+−
3CO], 246 (6) [M+−2-methyl 4,5-dihydrothiazole], 235
(49) [M+−4CO], 218 (7) [M+−2-methyl 4,5-dihy-
drothiazole–CO], 207 (30) [M+−5CO]. Anal. Found:
C, 44.49; H, 3.81; N, 4.33. C13H13CrNO5S (347.30).
Calc.: C, 44.96; H, 3.77; N, 4.03%.
9b: Yellow solid. Yield: 880mg (21% relative to
[Cr(CO)6]). M.p. 108°C. IR (CH2C12) w(CO) (cm−l):
2044 w, 1959 w, 1911 vs, 1900 vs. 1H-NMR
(CD3COCD3): l 1.59 and 1.91 (2 s, 3 H each,
CꢀCCH3), 2.31 (s, 3H, NꢀCCH3), 4.07 (dt, 2J=3J=8.7
2
Hz, 1H, NCH2), 4.71 (dt, J=3J=8.7 Hz, 1H, NCH2),
5.05 (t, 3J=8.7 Hz, 2H, OCH2). 13C-NMR
(CD3COCD3, for the numbering scheme see Fig. 2): l
12.61, 19.99 [C(8), C(9)], 26.13 [C(13)], 52.25 [C(12)],
70.28 [C(11)], 141.57, 154.53 [C(6), C(7)], 167.54
[C(10)], 221.81[cis-CO], 224.54 [trans-CO]. MS m/z (%):
331 (4) [M+], 303 (1) [M+−CO], 275 (1) [M+−2CO],
246 (8) [M+−2-methyl 4,5-dihydrooxazole], 218 (9)
[M+−2-methyl 4,5-dihydrooxazole–CO], 191 (25)
[M+−5CO]. Anal. Found: C, 47.20; H, 4.09; N, 4.43.
C13H13CrNO6 (331.21). Calc.: C, 47.14; H, 3.96; N,
4.23%.
10a: Yield: 200 mg (7.5% relative to [Cr(CO)6]). M.p.
67°C. IR (pentane): w(CO) (cm−l): 2067 w, 1934 vs,
1
1919 s. H-NMR (CD3COCD3): l 2.46 (s, 3H, CH3),
3
3
3.41 (t, J=6.9 Hz, 2H, SCH2), 4.37 (t, J=5.7 Hz,
2H, NCH2).